Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency
Measures acquisition + retention
Neither were published and Pliva was so excited about the results it abandoned the drug entirely One Phase I safety and pharmacokinetics trial of oral BPC-157, registered in 2015, that has no public results and appears to have been withdrawn or abandoned Three small and nonrandomized uncontrolled pilot studies from a single for-profit clinic in Florida, which included a 16-patient knee-pain chart review, a 12-woman interstitial cystitis study, and a small intravenous safety study One legitimate entry: a registered Phase 2 trial of BPC-157 for acute hamstring strain
Krishnaveni etal, 2009)
US$ 21.04
US$ 27.17
US$ 29.79
US$ 23.13
US$ 20.14
US$ 26.31
US$ 28.87
US$ 27.12
US$ 23.34
US$ 21.41
